While survival analysis in a cohort of 102 patients with oral SCCHN showed that high EZH2 levels predicted worse overall survival, no multivariate analysis was conducted to decipher its independence as a prognostic factor. The gene discussed is EZH2; the disease is head and neck squamous cell carcinoma.